Adynxx, Inc.
Adynxx, Inc. (ADYX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADYX · as of Jun 8, 2026
Key Statistics
Explore Adynxx, Inc. Data
adyx stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
adyx competitorsADYX
BGMD
BIMI
BNKL
CFRXQ
EFTRStock Performance
Full HistoryAbout Adynxx, Inc.
Adynxx, Inc. a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is…
what is adynxx, inc. · adyx stock overview · adynxx, inc. company profile · who is adynxx, inc. ceo · adyx OTC · adynxx, inc. headquarters · adynxx, inc. business segments
About Stock Overview & Key Data
Adynxx, Inc. (ADYX) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 18, 1998. As of the latest trading session, ADYX stock price is $0.00, with a market capitalization of $581. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2018, Adynxx, Inc. reported revenue of $2.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adynxx, Inc. (ADYX) stock price is $0.00. The stock is traded on OTC under the ticker symbol ADYX. The 52-week range is $0.00 – $0.00.